Alemtuzumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Alemtuzumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about SaveRxCanada.to
List of countries where we can ship Alemtuzumab:
Latest news releases on Alemtuzumab:
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, ...
L'alemtuzumab (commercialisé sous les noms de Campath, MabCampath, Campath-1H et plus récemment de Lemtrada) est un anticorps monoclonal IgG1 kappa humanisé ...
L'alemtuzumab è un anticorpo monoclonale umanizzato utilizzato contro la leucemia linfatica cronica. Per il suo meccanismo di azione favorisce la riuscita della lisi ...
Campath, alemtuzumab is a major step forward in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
Alemtuzumab BC Cancer Agency Cancer Drug Manual© Page 1 of 11 Alemtuzumab Developed: November 2006 Revised: 1 May 2015 DRUG NAME: Alemtuzumab
alemtuzumab etkin maddesi hakkında kısa bilgi. B-hücreli kronik lemfositik lösemide, rekombinant insan monoklonal antikoru. Haftada 3 gün 30mg/gün.
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)
Alemtuzumab, the anti-CD52 monoclonal antibody has shown its ability to reduce relapse rates in patients with multiple sclerosis (MS). Used in the treatment of ...
Return to Table of Contents. Campath ® (ALEMTUZUMAB) DESCRIPTION. Campath ® (Alemtuzumab) is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H ...
Get to know LEMTRADA. Hear from patients & specialists, find helpful resources & locate MS events near you. Learn more. See risks & benefits.